Key result
Transcatheter aortic valve implantation using the Inovare valve via transfemoral access was successfully performed in a high-risk patient with severe bioprosthesis dysfunction.
Case Report (n=1)
Transfemoral TAVI using the Inovare valve can be successfully performed in high-risk patients with degenerated surgical bioprostheses.
Demonstrates feasibility of transfemoral Inovare valve-in-valve TAVI in one high-risk patient; leaves open durability, safety, and generalizability.
We present a patient with severe aortic valvular bioprosthesis dysfunction implanted for 11 years, presenting with acute pulmonary edema due to severe valvular insufficiency with severe systolic dysfunction (EF <30%) and comorbid conditions that amounted operative risk (STS score > 10). We carried out the transcatheter aortic valve implantation (Inovare® - Braile Biomedica), which was implemented successfully by transfemoral access and good patient outcomes.
No takes yet. Share an insight, caveat, or question.
Pontes et al. (2012) conducted a case report in Severe aortic valvular bioprosthesis dysfunction (n=1). Transcatheter aortic valve implantation (Inovare®) via transfemoral access was evaluated on Procedural success and patient outcomes. Transcatheter aortic valve implantation using the Inovare valve via transfemoral access was successfully performed in a high-risk patient with severe bioprosthesis dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: